source
- Podcast interview challenges the scientific basis of blue zones after 25 years of hypeIn a recent First Opinion podcast, Eric Topol and Shelley Wood discuss the rise of the blue zone concept over the past quarter century. They note that the idea began with isolated communities said…
- FDA approves trastuzumab deruxtecan for early-stage HER2-positive breast cancerThe U.S. Food and Drug Administration has granted approval for trastuzumab deruxtecan (T‑DXd) as a treatment option in both the adjuvant and neoadjuvant settings for certain patients with early-sta…